IM Cannabis Achieves Positive Cash Flow in 2025 as German Revenue Surges 134%

Key Facts

1The company achieved revenue of C$54.7 million with over 134% growth in Germany.

2The company reported positive operating cash flow of C$4.7 million for the year 2025.

3This performance represents a significant turnaround from the negative cash flow recorded in 2024.

IM Cannabis Corp. (IMCC) announced its audited financial results for the full year 2025, marking a significant milestone in its operational and financial efficiency. The company reported total revenue of C$54.7 million, underpinned by an impressive 134% growth in its German operations. A key highlight of the report was the achievement of a positive operating cash flow of C$4.7 million, representing a major turnaround from the negative figures recorded in 2024. This financial recovery was further supported by successful financing transactions that bolstered the company's cash position and balance sheet stability. Management attributed the strong performance to the expansion of the medical cannabis market in Germany and optimized cost structures. The transition to profitability at the operating level positions IMCC favorably within the competitive global cannabis sector.